The British drugmaker reached an agreement with the Coalition for Epidemic Preparedness Innovations and Gavi, the Vaccine Alliance, to support the manufacturing, procurement and distribution of 300 million doses of the shot, according to a statement Thursday. Delivery will start by the end of the year.
In addition, the company reached a licensing agreement with the Serum Institute of India to supply 1 billion doses for low- and middle-income countries, with a commitment to provide 400 million ...